Humanized Ovarian Cancer Patient-Derived Xenografts for Improved Preclinical Evaluation of Immunotherapies

SIMPLE SUMMARY: Epithelial ovarian cancer (EOC) is a heterogenous disease and new combination therapies are employed to improve treatment, decrease disease recurrence, and avoid the development of treatment resistance. Immunotherapy has been suggested to boost the immune system and improve the progn...

Descripción completa

Detalles Bibliográficos
Autores principales: Kleinmanns, Katrin, Gullaksen, Stein-Erik, Bredholt, Geir, Davidson, Ben, Torkildsen, Cecilie Fredvik, Grindheim, Sindre, Bjørge, Line, McCormack, Emmet
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9265069/
https://www.ncbi.nlm.nih.gov/pubmed/35804867
http://dx.doi.org/10.3390/cancers14133092

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9265069/
https://www.ncbi.nlm.nih.gov/pubmed/35804867
http://dx.doi.org/10.3390/cancers14133092

Ejemplares similares